Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Antibody Responses in Adults and Elderly after Immunization with a Recombinant Pertussis Booster Dose
TCTR20190927006Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 3 trial in pertussis, sponsored by Chulalongkorn University. Started Feb 2020; status: completed.
02
Conditions
pertussis
Beyond the preview
Go deeper on TCTR20190927006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190927006.